Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Psychiatry Research

• Publication date

  2010-10-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2009.08.022PMID 20493536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COMT Val158Met moderation of cannabis‐induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life

  2009cited by this paper
• Untreated illness duration correlates with gray matter loss in first-episode psychoses

  2009cited by this paper
• Impact of cannabis and other drugs on age at onset of psychosis.

  2008cited by this paper
• Catechol‐O‐methyltransferase Val158Met polymorphism and clinical characteristics in first episode non‐affective psychosis

  2008influential reference
• Epidemiological factors associated with treated incidence of first‐episode non‐affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis

  2008cited by this paper
• Gene-environment interplay between cannabis and psychosis.

  2008cited by this paper
• Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.

  2007cited by this paper
• Duration of untreated psychosis and neuropsychological function in first episode psychosis.

  2007cited by this paper
• Low-activity allele of Catechol-O-Methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis.

  2007cited by this paper
• Is COMT a susceptibility gene for schizophrenia?

  2007cited by this paper
• Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.

  2007cited by this paper
• Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment

  2007cited by this paper
• Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia.

  2006cited by this paper
• Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.

  2006cited by this paper
• An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

  2006influential reference
• atechol-o-Methyltransferase , Cognition , nd Psychosis : Val 158 Met and Beyond

  2006cited by this paper
• Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients

  2006cited by this paper
• Catechol‐O‐methyltransferase and the clinical features of psychosis

  2006cited by this paper
• Gray matter abnormalities associated with duration of untreated psychosis.

  2006cited by this paper
• A population based elaboration of the role of age of onset on the course of schizophrenia.

  2006cited by this paper
• Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.

  2005cited by this paper
• Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: a population study in 543 young men.

  2004cited by this paper
• Cannabis use and age at onset of schizophrenia.

  2004cited by this paper
• Pathways to schizophrenia: the impact of environmental factors.

  2004cited by this paper
• Association Study of a Functional Catechol-O-Methyltransferase Genetic Polymorphism with Age of Onset, Cognitive Function, Symptomatology and Prognosis in Chronic Schizophrenia

  2004cited by this paper
• Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

  2004cited by this paper
• Testing hypotheses about the relationship between cannabis use and psychosis.

  2003cited by this paper
• Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.

  2003cited by this paper
• Relationship between catechol‐O‐methyltransferase polymorphism and treatment‐resistant schizophrenia

  2003cited by this paper
• Family history of psychiatric disorders and age at first contact in schizophrenia: An epidemiological study

  2002cited by this paper
• Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

  2002cited by this paper
• Prefrontal neurons and the genetics of schizophrenia.

  2001cited by this paper
• Sex differences in schizophrenia, a review of the literature.

  2000cited by this paper
• Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

  1999cited by this paper
• Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

  1999cited by this paper
• Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription.

  1999cited by this paper
• Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat

  1998cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet

  1997cited by this paper
• The genetic epidemiology of schizophrenia and the design of linkage studies

  1991cited by this paper
• A chart review study of late-onset and early-onset schizophrenia.

  1989cited by this paper
• Analysis of variance in complex experimental designs

  1974cited by this paper

• Exploring the Role of CACNA1C, ZNF804A and SLC6A4 in Schizophrenia through Epigenomics and Bioinformatics

  2025cites this paper
• Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment

  2023cites this paper
• Early-onset schizophrenia is associated with immune-related rare variants in a Chinese sample

  2023cites this paper
• The genetic basis of onset age in schizophrenia: evidence and models

  2023cites this paper
• Early intervention: factors associated with the increasing of the duration of untreated psychosis (DUP) - a systematic review

  2020cites this paper
• Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006-2015.

  2020cites this paper
• Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review

  2020cites this paper
• Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans

  2019cites this paper
• Cannabis and Psychosis Through the Lens of DSM-5

  2019cites this paper
• Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis.

  2019cites this paper
• Tetrahydrocannabinol levels are too high in many hemp-containing foods - health impairments are possible

  2019cites this paper
• Clearing the Smoke on Cannabis: Regular Use and Mental Health

  2019cites this paper
• Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic Disorders

  2018cites this paper
• Independent associations and effect modification between lifetime substance use and recent mood disorder diagnosis with household food insecurity

  2018cites this paper
• Meta-analysis of neurocognition in young psychosis patients with current cannabis use.

  2018cites this paper
• The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta – analysis

  2018cites this paper
• Psychotomimetic and Cognitive Effects of Δ9-Tetrahydrocannabinol in Laboratory Settings

  2018cites this paper
• Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use

  2017cites this paper
• Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review

  2017cites this paper
• Cannabis use, COMT, BDNF and age at first-episode psychosis.

  2017cites this paper
• The effect of interactions between genetics and cannabis use on neurocognition. A review

  2017cites this paper
• COMT Genotypes, Cannabis Use, and Psychosis: Gene-Environment Interaction Evidence from Human Populations, and Its Methodological Concerns

  2017cites this paper
• COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.

  2016cites this paper
• Human Laboratory Studies on Cannabinoids and Psychosis.

  2016cites this paper
• Pathways to psychosis in cannabis abuse.

  2015cites this paper
• A disfunção dopaminérgica mesolímbica na psicose: uma revisão da literatura

  2015cites this paper
• Clearing the Smokescreen: The Current Evidence on Cannabis Use

  2015influential citation
• The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.

  2015cites this paper
• Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones.

  2014cites this paper
• [Can we draw an identikit of cannabis smokers who may be at higher risk of developing a psychosis?].

  2014cites this paper
• Cannabis and psychosis: Neurobiology

  2014cites this paper
• Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis.

  2014cites this paper
• Nature-Nurture Integration

  2014cites this paper
• Genetic dissection of the psychotomimetic effects of cannabinoid exposure.

  2014cites this paper
• Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia

  2013cites this paper
• Cannabis and Psychosis: A Systematic Review of Genetic Studies

  2013influential citation
• Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness

  2013cites this paper
• Substance abuse and psychosis.

  2013cites this paper
• Age at onset of schizophrenia: cannabis, COMT gene, and their interactions.

  2013cites this paper
• Pathways from Cannabis to Psychosis: A Review of the Evidence

  2013cites this paper
• Cannabinoids, Monoamines, COMT and Schizophrenia: Pathobiological Mechanisms in Psychosis

  2013cites this paper
• Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.

  2012cites this paper
• Cannabis use and psychosis: theme introduction.

  2012cites this paper
• Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis.

  2012cites this paper
• Gene-environment interactions underlying the effect of cannabis in first episode psychosis.

  2012influential citation
• Catechol-O-methyl transferase as a drug target for schizophrenia.

  2012cites this paper
• No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population

  2012cites this paper
• Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis

  2012cites this paper
• Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender

  2012influential citation
• The prevention of schizophrenia--what can we learn from eco-epidemiology?

  2011cites this paper
• Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism

  2011cites this paper
• eview ffects of COMT polymorphisms on brain function and behavior in health and isease

  2011cites this paper
• Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment

  2011cites this paper
• The Interface of Cannabis Misuse and Schizophrenia-Spectrum Disorders

  2011cites this paper
• Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

  2011cites this paper
• Schizophrenia as a disorder of too little dopamine : implications for symptoms & treatment association and limbic areas of the cortex converge on differ

  2008cites this paper